Navigation Links
Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
Date:4/30/2008

598 in patients with chronic hepatitis

C virus (HCV) infection in the third quarter of 2008.

-- Initiation of Phase I Clinical Trial for ANA773. In late February,

Anadys announced that patient dosing had commenced in a Phase I study

of ANA773, the Company's oral TLR7 agonist prodrug, in patients with

advanced solid tumors. This first-in-human trial is a safety and

tolerability study designed to identify pharmacologically active doses

and preliminary antitumor activity as well as to select the dose and

schedule for Phase II trials.

Recent Scientific Presentations

-- ANA598. Earlier this month, Anadys presented a late-breaker oral

presentation at the 21st International Conference on Antiviral Research

(ICAR) in Montreal providing updated preclinical data on ANA598. The

data presented at ICAR included preclinical attributes of the product

candidate that support the potential for beneficial combination of

ANA598 with several other anti-HCV agents. Specifically, ANA598 was

reported to be highly synergistic with interferon-alpha and

non-antagonistic with ribavirin in cell-based assays. ANA598 was also

shown to retain full activity against a number of replicon mutations

known to confer resistance to other anti-HCV agents currently in

clinical development, including protease inhibitors and nucleoside

polymerase inhibitors.

-- ANA773. Anadys presented data on ANA773 earlier this month in two

poster sessions at the Annual Meeting of the American Association for

Cancer Research (AACR) in San Diego. One of the posters, based on work

done with the Moores Cancer Center at the University of California San

Diego, reported the pro-apoptotic effect of the active metabolite of

ANA773 on human chronic lymphocytic leukemia (CLL) cells ex vivo, and'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results
2. Anadys Pharmaceuticals to Present at the CanAccord Adams Hepatitis C Conference
3. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
4. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
5. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
6. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
9. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
11. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Understanding the need for better quality and ... gap that currently exists in this area, ChanTest has ... of validated ion channel and GPCR cell lines. ... ion channels control many critical physiological functions throughout the ... potential to treat a variety of human diseases. ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 OMICS Group’s ... techniques during 18-20 August, 2014 at Double Tree by ... the recent developments in Analytical & Bioanalytical research methods ... , Speaking on this occasion, Dr. Srinubabu Gedela, MD ... Acta conference is a remarkable one in bringing a ...
(Date:7/10/2014)... , July 10, 2014 On ... Dmitry Medvedev , presented Russia,s ... BIOCAD . The Company is developing a unique project ... project BIOCAD develops a number of innovative drugs based ... diseases. The ceremony took place at the International Exhibition ...
(Date:7/10/2014)... 10, 2014   Ceres, Inc . (Nasdaq: ... announced today financial results for the three months ended ... business. Ceres reported that the company and ... this growing season in Brazil, which concluded in June, ... sorghum evaluation areas for part of the growing season. ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... 21, 2011  Palatin Technologies, Inc. (NYSE Amex: PTN ... Annual BIO Investor Forum on Wednesday, October 26, 2011 at ... (BIO), the 10th Annual BIO Investor Forum will take place ... Carl Spana, Ph.D., President and Chief Executive ...
... at Emory University have solved an important mystery about the ... The findings, published in the journal Science , ... the known rules, a problem that has baffled physical chemists ... pre-reactive, long-range force can align the reaction of a chorine ...
... Oct. 20, 2011 BioStorage Technologies, Inc. a ... storage and cold chain logistics for the bioscience ... Symposium at the International Contract Services Expo (ICSE), ... The symposium will include two ...
Cached Biology Technology:Chemists find new dimension to rules for reactions 2Chemists find new dimension to rules for reactions 3BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo 2
(Date:7/10/2014)... SPRINGS, Colo. , June 27, 2014 /PRNewswire/ ... that the National Institute of Standards and Technology ... 10 of its academic research and forensic science ... (FSSB).  The Board is an element of the ... AAFS members are among the first appointments made ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... , Unisys Nederland N.V., today announced that it has been ... implement and manage a new Basic Provision Biometrics solution for ... Unisys won the contract with a solution based on ... software. The term of the contract is up to seven ...
(Date:7/10/2014)... , July 3, 2014 Research and ... of the "Global Gesture Recognition & Touch-Less ... Forecasts to 2020" report to their offering ... Global Gesture Recognition & Touch-Less Sensing Market to ... for a while, but the companies were unable ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Global Gesture Recognition & Touch-Less Sensing (2D, 3D, Ultrasonic, IR, Capacitive) Market - Forecasts to 2020 2
... PORTLAND, Ore. February 1, 2011. Fact: ... the temperature of the nest: warm nests produce females, cooler ... planet for about 220 million years, scientists now report that ... are working to understand how global warming may affect turtle ...
... S.C. The furry-looking insects start their development smaller ... soon develop an appetite for cotton as big as ... Clemson University entomologist Jeremy Greene planted two cotton varieties ... one not in a demonstration field at the ...
... HOUSTON -- (Feb. 1, 2011) -- Rice University ... Texas Children,s Hospital have successfully destroyed tumors of human ... a minimally invasive treatment that zaps glioma tumors with ... designed to destroy tumors with heat and avoid the ...
Cached Biology News:Turtle populations affected by climate, habitat loss and overexploitation 2Technology protects cotton from caterpillar's appetite 2Early tests find nanoshell therapy effective against brain cancer 2
... nature of proteomics demands the detection of ... performance of the AXIMA-CFRplus with improved resolution ... ppm) provides increased confidence in protein identification. ... enhanced sensitivity, automated sample target handling and ...
...
... MALDI O-TOF creates a new category for ... platform that has been licensed to the ... Manitoba. , As the first single MALDI-TOF ... collisional cooling, the prOTOF 2000 represents a ...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
Biology Products: